| Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury U Wilhelmsson, EA Bushong, DL Price, BL Smarr, V Phung, M Terada, ... Proceedings of the National Academy of Sciences 103 (46), 17513-17518, 2006 | 822 | 2006 |
| The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease DL Price, MA Koike, A Khan, W Wrasidlo, E Rockenstein, E Masliah, ... Scientific reports 8 (1), 16165, 2018 | 167 | 2018 |
| A de novo compound targeting α-synuclein improves deficits in models of Parkinson’s disease W Wrasidlo, IF Tsigelny, DL Price, G Dutta, E Rockenstein, TC Schwarz, ... Brain 139 (12), 3217-3236, 2016 | 165 | 2016 |
| Distribution of rSlo Ca2+-activated K+ channels in rat astrocyte perivascular endfeet DL Price, JW Ludwig, H Mi, TL Schwarz, MH Ellisman Brain research 956 (2), 183-193, 2002 | 145 | 2002 |
| The cell-centered database: a database for multiscale structural and protein localization data from light and electron microscopy ME Martone, S Zhang, A Gupta, X Qian, H He, DL Price, M Wong, ... Neuroinformatics 1, 379-395, 2003 | 126 | 2003 |
| Automated microscopy system for mosaic acquisition and processing SK Chow, H Hakozaki, DL Price, NAB MacLean, TJ Deerinck, JC Bouwer, ... Journal of microscopy 222 (2), 76-84, 2006 | 121 | 2006 |
| Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy–implications for excitotoxicity DL Price, E Rockenstein, K Ubhi, V Phung, N MacLean-Lewis, D Askay, ... PloS one 5 (11), e14020, 2010 | 88 | 2010 |
| Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5–implications for dementia with Lewy bodies CR Overk, A Cartier, G Shaked, E Rockenstein, K Ubhi, B Spencer, ... Molecular neurodegeneration 9, 1-18, 2014 | 77 | 2014 |
| Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease K McFarland, DL Price, DW Bonhaus Behavioural pharmacology 22 (7), 681-692, 2011 | 76 | 2011 |
| Characterization of the disruptions of prepulse inhibition and habituation of startle induced by α-ethyltryptamine DL Martinez, MA Geyer Neuropsychopharmacology 16 (3), 246-255, 1997 | 71 | 1997 |
| Longitudinal live imaging of retinal α-synuclein:: GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies DL Price, E Rockenstein, M Mante, A Adame, C Overk, B Spencer, ... Scientific reports 6 (1), 29523, 2016 | 54 | 2016 |
| Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer’s disease DL Price, DW Bonhaus, K McFarland Behavioural Pharmacology 23 (4), 426-433, 2012 | 48 | 2012 |
| AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson’s disease rat model K McFarland, DL Price, CN Davis, JN Ma, DW Bonhaus, ES Burstein, ... ACS chemical neuroscience 4 (9), 1249-1255, 2013 | 47 | 2013 |
| Collaborative development of the Arrowsmith two node search interface designed for laboratory investigators NR Smalheiser, VI Torvik, A Bischoff-Grethe, LB Burhans, M Gabriel, ... Journal of biomedical discovery and collaboration 1 (1), 1-18, 2006 | 45 | 2006 |
| Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons ML Berlanga, DL Price, BS Phung, R Giuly, M Terada, N Yamada, M Cyr, ... Brain research 1390, 41-49, 2011 | 37 | 2011 |
| High-resolution large-scale mosaic imaging using multiphoton microscopy to characterize transgenic mouse models of human neurological disorders DL Price, SK Chow, NAB MacLean, H Hakozaki, S Peltier, ME Martone, ... Neuroinformatics 4, 65-80, 2006 | 37 | 2006 |
| Neuroprotective effects of the anti‐cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders W Wrasidlo, LA Crews, IF Tsigelny, E Stocking, VL Kouznetsova, D Price, ... British journal of pharmacology 171 (24), 5757-5773, 2014 | 29 | 2014 |
| Subthalamic 5-HT1A and 5-HT1B receptor modulation of RU 24969-induced behavioral profile in rats DL Martinez-Price, MA Geyer Pharmacology Biochemistry and Behavior 71 (4), 569-580, 2002 | 25 | 2002 |
| NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson’s disease A Khan, R Johnson, C Wittmer, M Maile, K Tatsukawa, JL Wong, MB Gill, ... Brain 144 (12), 3692-3709, 2021 | 17 | 2021 |
| In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease DL Price, A Khan, R Angers, A Cardenas, MK Prato, M Bani, DW Bonhaus, ... npj Parkinson's Disease 9 (1), 114, 2023 | 15 | 2023 |
